Development and validation of a novel clinical decision support tool for sustained remission in Crohn's disease: a multi-center real-world study
{{output}}
Background and aims: Long-term outcomes for Crohn's disease (CD) patients treated with infliximab (IFX) remain suboptimal. We developed and validated a clinical decision support tool (CDST) to predict sustained remission in CD p... ...
